# OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure

Study · id `cardio:ct-nct04691687` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04691687](<https://clinicaltrials.gov/study/NCT04691687>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04691687

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

## Technical summary

Registry record NCT04691687. Randomized; quadruple masking; primary purpose treatment. Start 2012-05-01 (actual); primary completion 2017-12-22 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 100 participants (enrolled count; ClinicalTrials.gov record NCT04691687, source copy `cardio:ctgov-nct04691687-2020-12-31`, retrieved 2026-10-26)
- Started: 2012-05-01 (actual) (ClinicalTrials.gov record NCT04691687, source copy `cardio:ctgov-nct04691687-2020-12-31`, retrieved 2026-10-26)
- Primary completion: 2017-12-22 (actual) (ClinicalTrials.gov record NCT04691687, source copy `cardio:ctgov-nct04691687-2020-12-31`, retrieved 2026-10-26)
- Completion: 2017-12-22 (actual) (ClinicalTrials.gov record NCT04691687, source copy `cardio:ctgov-nct04691687-2020-12-31`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04691687-2020-12-31`, retrieved 2026-10-26)

## The registry's words

- Brief title: OUTpatient Intravenous LASix Trial in Reducing Hospitalization for Acute Decompensated Heart Failure
- Acronym: OUTLAST
- Condition: Heart Failure
- Intervention (Drug): Furosemide
- Intervention (Drug): IV Solution
- Lead sponsor: New York Presbyterian Brooklyn Methodist Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)

## Provenance

Content hash: 14b73dc74916b15e0714aff061100ee37b626e1a5ac031a51bbb0a554f1995d9
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
